Patients with diagnosis of multiple myeloma according to criteria of the International Myeloma Working Group 
Patients in whom a LEN-DEX-based treatment regimen is indicated 
Adult patients ≥ 19 years of age who are able to freely provide informed consent 

NCT02749617_inc_T1
Condition
multiple myeloma
NCT02749617_inc_T2
Measurement
criteria of the International Myeloma Working Group
NCT02749617_inc_T6
Drug
DEX
NCT02749617_inc_T7
Drug
LEN
NCT02749617_inc_T8
Qualifier
LEN-DEX-based
NCT02749617_inc_T9
Procedure
treatment regimen
NCT02749617_inc_T10
Mood
is indicated
NCT02749617_inc_T11
Person
Adult
NCT02749617_inc_T12
Value
≥ 19 years
NCT02749617_inc_T13
Person
age
NCT02749617_inc_T14
Observation
able to freely provide informed consent